Precision BioSciences, Inc. - Common Stock (NQ:DTIL)
5.030
+0.170
(+3.50%)
Streaming Delayed Price
Updated: 12:26 PM EST, Dec 10, 2025
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 76,548 |
| Open | 4.860 |
| Bid (Size) | 4.990 (100) |
| Ask (Size) | 5.070 (300) |
| Prev. Close | 4.860 |
| Today's Range | 4.750 - 5.040 |
| 52wk Range | 3.810 - 8.770 |
| Shares Outstanding | 113,793,338 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Earnings Scheduled For November 3, 2025 ↗
November 03, 2025
Earnings Scheduled For August 7, 2025 ↗
August 07, 2025
DTIL Revenue Drops 99% ↗
August 07, 2025
Frequently Asked Questions
Is Precision BioSciences, Inc. - Common Stock publicly traded?
Yes, Precision BioSciences, Inc. - Common Stock is publicly traded.
What exchange does Precision BioSciences, Inc. - Common Stock trade on?
Precision BioSciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Precision BioSciences, Inc. - Common Stock?
The ticker symbol for Precision BioSciences, Inc. - Common Stock is DTIL on the Nasdaq Stock Market
What is the current price of Precision BioSciences, Inc. - Common Stock?
The current price of Precision BioSciences, Inc. - Common Stock is 5.030
When was Precision BioSciences, Inc. - Common Stock last traded?
The last trade of Precision BioSciences, Inc. - Common Stock was at 12/10/25 12:26 PM ET
What is the market capitalization of Precision BioSciences, Inc. - Common Stock?
The market capitalization of Precision BioSciences, Inc. - Common Stock is 572.38M
How many shares of Precision BioSciences, Inc. - Common Stock are outstanding?
Precision BioSciences, Inc. - Common Stock has 572M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.